Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...
Most recently, Amgen shares advanced in 2Q following its announcement that its novel injectable GLP-1 agonist / GIPR antagonist, MariTide, for obesity showed promising interim Phase 2 data and has ...
High dividend yields are not always as great as they may seem. Remember that a dividend yield is arrived at by dividing a stock's annual dividend amount by its current stock price.
THOUSAND OAKS, Calif., Feb. 14, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at Citi's 2025 Virtual Oncology Leadership Summit at 3:00 p.m. ET on Wednesday, Feb. 19, 2025. Jean-Charles ...
Amgen Inc. has a fifty-two week low of $253.30 and a fifty-two week high of $346.85. The firm’s 50-day simple moving average is $273.29 and its two-hundred day simple moving average is $302.18.
Biotechnology company, Amgen, has announced that it has entered into a definitive agreement to acquire deCODE Genetics, a global leader in human genetics, for US $415 million. The all-cash ...
Amgen’s next-generation cholesterol drug has shown it can reverse the build up of plaque build-up in coronary arteries which can lead to a heart attack or stroke. The company’s Repatha ...
Oppenheimer lowered the firm’s price target on Ideaya Biosciences (IDYA) to $40 from $53 and keeps an Outperform rating on the shares after the company and Amgen (AMGN) mutually agree to wind ...
Judge Declines to Block Musk From Accessing Agency Records or Ordering Firings Musk team’s next target is probationary Pentagon employees. Patel clears a procedural hurdle in the Senate, putting ...
Tejashwi Yadav criticizes the newly appointed CEC, accusing the EC of bias towards the BJP and eroding public trust. He recalls alleged manipulation in the 2020 Bihar polls and vows to remove EVMs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results